TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
SCYX

Scynexis Inc

Healthcare · Drug Manufacturers - Specialty & Generic

5.10$ -4.7% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Cash Flow

Scynexis Inc (SCYX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -5.3 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow SCYX
Line item 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-11 -4.3 -9.5 -25 -29 -25 -28 -38 -49 -55 -80 60 -24 -5.3
1.5 1.3 1.2 0.4 0.0 0.0 0.1 0.1 0.1 0.4 0.6 0.6 1.7 0.3
0.4 0.2 1.2 3.0 1.2 1.7 1.8 1.8 2.2 2.1 3.7 2.6 3.3 2.9
– – -7.5 6.3 3.2 -1.1 -10 5.8 7.7 -27 – – – –
-0.1 3.5 0.6 4.1 -3.0 1.0 -6.4 8.3 -3.2 3.1 0.8 -31 7.3 6.1
0.4 0.4 0.7 0.6 0.0 0.0 0.6 0.0 0.0 1.2 0.0 60 0.0 0.0
3.1 0.6 -0.5 1.6 -22 -9.6 -0.8 26 6.5 -1.2 -27 -35 6.2 24
– – 0.0 0.0 0.0 0.0 – – 10 – – – – –
– – 63 42 28 10 32 46 -0.2 39 – – – –
– – -6.9 -3.8 12 -0.3 -2.3 -1.2 10 29 5.0 -37 0.0 -14
6.0 2.8 41 38 40 10.0 29 42 94 67 49 -37 -0.1 -14
-1.6 -1.0 31 15 -11 -24 0.3 30 51 11 -59 -11 -18 4.9
-11 -4.7 -10 -25 -29 -25 -29 -38 -49 -56 -80 60 -24 -5.3

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?